HighPoint Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $98K | Buy |
+10,056
| New | +$98K | 0.01% | 535 |
|
|
2019
Q3 | – | Sell |
-12,356
| Closed | -$95K | – | 517 |
|
|
2019
Q2 | $95K | Sell |
12,356
-564
| -4% | -$4.34K | 0.02% | 471 |
|
|
2019
Q1 | $188K | Buy |
12,920
+1,035
| +9% | +$15.1K | 0.05% | 314 |
|
|
2018
Q4 | $214K | Buy |
11,885
+1,153
| +11% | +$20.8K | 0.06% | 280 |
|
|
2018
Q3 | $228K | Buy |
+10,732
| New | +$228K | 0.06% | 276 |
|
|
2017
Q1 | – | Sell |
-6,250
| Closed | -$219K | – | 301 |
|
|
2016
Q4 | $219K | Buy |
6,250
+1,010
| +19% | +$35.4K | 0.07% | 254 |
|
|
2016
Q3 | $204K | Buy |
5,240
+916
| +21% | +$35.7K | 0.07% | 256 |
|
|
2016
Q2 | $231K | Buy |
+4,324
| New | +$231K | 0.08% | 238 |
|